Our study indicates that STZ administration leads to a complex mechanism of diabetes and hypertension development, possibly due to the enhanced oxidative stress, indicated by increased MDA and decreased plasma SOD, NOx, and TOC levels. This evidence concerns the gene SOD1 and Hypertension.